Skip to search formSkip to main contentSkip to account menu

Yondelis

National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

trabectedin
trabectedin 1 MG Injection [Yondelis]trabectedin Injection [Yondelis]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
[Report from a small registry-permetrexed, tarceva and yondelis].
2013
2013
13 years of trabectedin, 5 years of Yondelis®: what have we learnt?
Trabectedin (Yondelis® [PharmaMar S.A., Madrid, Spain]) is one of the most promising agents tested in the last two decades in… 
2011
2011
Preclinical Development Trabectedin and Its C Subunit Modified Analogue PM 01183 Attenuate Nucleotide Excision Repair and Show Activity toward Platinum-Resistant Cells
PM01183 is a novel marine-derived covalent DNA binder in clinical development. PM01183 is structurally similar to trabectedin… 
Review
2009
Review
2009
Clinical Outcome of ET-743 (Trabectedin; Yondelis) in High-Grade Uterine Sarcomas: Report on Five Patients and a Review of the Literature
Abstract The clinical impact of ET-743 (trabectedin; Yondelis) in women with leiomyosarcoma and undifferentiated uterine sarcoma… 
2005
2005
DNA Structural Similarity in the 2:1 Complexes of the Antitumor Drugs Trabectedin (Yondelis) and Chromomycin A3 with an Oligonucleotide Sequence Containing Two Adjacent TGG Binding Sites on Opposing…
Yondelis (trabectedin) is an antitumor ecteinascidin that binds covalently to the 2-amino group of the central guanine in the… 
2004
2004
The unique biological features of the marine product Yondelis (ET-743, trabectedin) are shared by its analog ET-637, which lacks the C ring.
It was previously suggested that the peculiar mechanism of action of the novel anticancer drug Yondelis (ET-743, trabectedin) was… 
2004
2004
Simple and sensitive liquid chromatographic quantitative analysis of the novel marine anticancer drug Yondelis (ET-743, trabectedin) in human plasma using column switching and tandem mass…
The development of a simple and sensitive assay for the quantitative analysis of the marine anticancer agent Yondelis (ET-743… 
2003
2003
Rationale for drug combinations.
2003
2003
573 Safety profile for yondelis (ET-743) 1.3 mg/m2 over 3 hours (h)
Review
2003
Review
2003
Therapeutic impact of ET-743 (Yondelis; trabectidin), a new marine-derived compound, in sarcoma
“Nature distributed medicine everywhere.”Purpose of reviewThe therapeutic pharmacologic armamentarium in sarcoma is limited, and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)